Price
No data yet.
Social Signal Score
Revenue
$0.00Company Profile
- CEO
- Jack E. Stover
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 2
- Beta
- 0.47
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- -374.84
Financials
PFSA has only 11 quarterly periods on file — the charts below show the full history available.
Net Income
$-8.76M-3810.2%EBITDA
$-2.54M-1069.7%Free Cash Flow
$-2.71MEPS (diluted)
$-151.80-5263.3%Shares Outstanding (diluted)
57.7K-28.2%Operating Expenses
$2.54MCash & Debt
$719.0KReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-35.82M | $-107.01 |
| 2024 | $0.00 | $-9.23M | $-357.13 |
| 2023 | $0.00 | $-10.28M | $-76.65 |
| 2022 | $0.00 | $-20.22M | $-62.74 |
| 2021 | $0.00 | $-10.31M | $-31.99 |
Valuation
PFSAhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100+0.00%Social Signal Score
Mentions (3)
- Newsbenzinga.com·11d ago·Neutral
Micro Cap Profusa Navigates European Regulatory Hurdles to Advance Oxygen Monitoring Tech Micro cap Profusa, Inc. (NASDAQ:PFSA) stock is surging on Thursday after the company received a positive decision from GMED regarding the certification of its quality management system to ISO 13485.
View source ↗ - Newsglobenewswire.com·47d ago·Negative
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company Debt and liabilities holders have executed $10.7 million of Series A Convertible Exchange Agreements; of which $4.57 million was converted into Series A Convertible Preferred Stock
View source ↗ - Newsglobenewswire.com·54d ago·Neutral
Profusa Announces 1-for-4 Reverse Stock Split BERKELEY, California, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual's biochemistry, today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to effect a one-for-four (1:4)…
View source ↗
Insider trading
Open-market buys and sells by PFSA officers and directors.
- Bought
- $37k
- Sold
- $153k
8 trades
6 trades
- Hrt Financial Lpsold
- Hrt Financial Lpsold
- Hrt Financial Lpsold
- Hrt Financial Lpbought
- Hrt Financial Lpsold
- Hrt Financial Lpbought
- Hrt Financial Lpsold
- Hrt Financial Lpbought
29 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in PFSA.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.